HAV Vaccines
"Inactivated Hepatitis A Vaccine in Healthy Chinese Adults."
Published in Hepatitis Weekly, March 18th, 1996
According to the authors' abstract of an article published in Journal of Internal Medicine, "Objectives: To study the safety, tolerability of and immune response to an inactivated hepatitis A vaccine in healthy Chinese adults. Design: Seronegative subjects were randomized to receive formalin-inactivated, alum-adjuvanted hepatitis A vaccine (25 units, MSD) at 0, 24 weeks (group I) or 0, 2, 24 weeks (group II). Subjects: Healthy Chinese adults aged 18 years or above were recruited. All subjects were staff of a regional hospital and primary care clinic in Hong Kong. Main Outcome Measures: Side-effects, tolerance, seroconversion rate and geometric mean...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1996-03-18)
More Articles from Hepatitis Weekly
- Diagnostics
Molecular Typing More Sensitive Than Serotyping in HCV - Drug Development
(beta)-L-F-ddC Inhibits Duck HBV - Extrahepatic Manifestations
Leukocytoplastic Vasculitis Associated with HCV Vaccine - Liver Disease
Genetics Study Eyes Therapy To Treat Diseases - Pathogenesis (HBV)
TGF-(beta)1 Expression Regulated by HBx Transactivator - Prognostic Factors
Serum TGF-(alpha) Indicative of Liver Regeneration - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
